Pharmaceuticals News and Research

RSS

ATS receives a US $3.8 million order for a manufacturing system for new drug delivery technology

ATS Automation Tooling Systems Inc.has announced it has received a US $3.8 million (CDN $5.0 million) order from one of the world's largest pharmaceutical companies to provide a manufacturing system for a new drug delivery technology.

10 Jul 2004

Health Canada warning on Trazodone interaction with certain medications

Health Canada, in association with Bristol-Myers Squibb Canada, is advising Canadians to consult with their health care professionals if they are currently being treated with the antidepressant trazodone in combination with any of the following medications: ketoconazole (an antifungal agent), ritonavir and indinavir (protease inhibitors used in the treatment of HIV), or carbamazepine (an anti-epileptic therapy).

9 Jul 2004

Patient care violations at Sutter Solano Medical Center pose serious threats to the health and safety of patients

The Centers for Medicare and Medicaid, a federal agency within the U.S. Dept. of Health and Human Services, has concluded an investigation into patient care violations at Sutter Solano Medical Center that pose an “immediate and serious threat to the health and safety of patients.”

9 Jul 2004

Pfizer donates $3.7 million worth of Nicotrol patches to the New York City Department of Health

To help smokers quit, Pfizer is donating $3.7 million worth of eight-week courses of the Nicotrol patch, a leading nicotine replacement therapy (NRT), to the New York City Department of Health and Mental Hygiene (DOHMH).

9 Jul 2004

AIDS Healthcare Foundation, AIDS Therapeutic Treatment Now Coalition to unveil ambitious pledge at Bangkok 2004

Plans for advocacy, activism and protests throughout the weeklong AIDS conference to highlight the pressing need for increased access to life-saving anti-retroviral therapy (ARV) worldwide.

8 Jul 2004

Endo announces agreement With FDA for new trial design of oxymorphone extended-release tablets

Endo Pharmaceuticals Inc., a wholly owned subsidiary of Endo Pharmaceuticals Holdings Inc., today announced that it has reached agreement with the U.S. Food and Drug Administration

7 Jul 2004

Pfizer focuses on enabling America's 43 million uninsured to obtain medicines at significant savings

Pfizer Inc said today it will launch the pharmaceutical industry's most comprehensive initiative to significantly expand access to prescription medicines across the United States, with a specific focus on enabling America's 43 million uninsured to obtain Pfizer medicines at significant savings.

7 Jul 2004

Presidential Decree will have a direct negative impact on the health of millions of Ecuadorians

The international medical humanitarian organization Médecins Sans Frontières fears that a new Presidential Decree will make it much more difficult to obtain affordable essential medicines in Ecuador.

6 Jul 2004

Nanotechnology-based applications are accelerating the development of nanomedicine

With the potential for targeted therapy, and therefore reduced side effects, nanomedicine holds the promise of significantly improving quality of life parameters.

5 Jul 2004

Enzymes from king crab are an effective treatment for scalds, sores, and trophic ulcers

Chemist Galina Rudenskaya from the Moscow State University and her colleagues from small enterprise TRINITA have made an important discovery in medicine, thanks to funding extended by the RFBR and FASIE.

2 Jul 2004

Medicine storage temperatures are too high

The recommended maximum storage and transit temperatures for most medications is 25°C and are set by the pharmaceutical manufacturers.

2 Jul 2004

Gum disease vaccination aim of world-first research

Vaccinating people against gum disease will be the aim of world-first Melbourne research that today receives a $21.2 million boost from the Federal Government.

2 Jul 2004

Generic fixed-dose combinations (FDCs) of antiretrovirals are a key factor in access to treatment of HIV/AIDS infection in the developing world

Combination therapy with three generic antiretroviral drugs in a single tablet has been validated for the first time in an open clinical study in a developing country. Follow-up of 60 patients treated in Yaoundé, Cameroon, has demonstrated the excellent efficacy and safety of a generic fixed-dose combination.

2 Jul 2004

No compulsory genetic testing for newborn babies in Europe

European Research Commissioner Philippe Busquin today rejected stories in several media claiming he had called for genetic testing of all newborn babies in Europe.

2 Jul 2004

U.S. drug prices rise by 3.4 percent during the first quarter of 2004, elderly especially hard hit

A new study released by AARP finds manufacturers' wholesale prices for the 197 brand name prescription drugs most frequently used by older Americans continued an upward climb.

1 Jul 2004

New drug application for cilansetron, an investigational product for the treatment of irritable bowel syndrome

Solvay Pharmaceuticals, Inc. has submitted a New Drug Application (NDA) for cilansetron, an investigational product being studied for the treatment of irritable bowel syndrome with diarrhea predominance (IBS-D), to the FDA on June 30, 2004.

1 Jul 2004

New web site dedicated to improving the accuracy of medical news stories

The Newcastle Institute of Public Health (NIPH) has launched a web site dedicated to improving the accuracy of news stories about new medical treatments in the media.

1 Jul 2004

New drug application for regulatory approval of exenatide for the treatment of type 2 diabetes

Amylin Pharmaceuticals, Inc., and Eli Lilly and Company today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for regulatory approval of exenatide.

1 Jul 2004

A Center for Human Genetics/Genomics has been established at the University of California

Established in UCSD Health Sciences, which includes the School of Medicine and School of Pharmacy and Pharmaceutical Sciences, the Center brings together UCSD faculty from multiple campus departments and schools including medicine, pharmacy, biology, biostatistics and mathematics.

30 Jun 2004

Ethical, social and legal aspects of human genetic testing

On 6th and 7th May 2004, the European Commission invited all interested parties to attend a European citizens' and stakeholders' conference, held in Brussels, to discuss the ethical, social and legal aspects of human genetic testing in research and healthcare applications.

30 Jun 2004

Pharmaceuticals News and Research

ATS receives a US $3.8 million order for a manufacturing system for new drug delivery technology

Health Canada warning on Trazodone interaction with certain medications

Patient care violations at Sutter Solano Medical Center pose serious threats to the health and safety of patients

Pfizer donates $3.7 million worth of Nicotrol patches to the New York City Department of Health

AIDS Healthcare Foundation, AIDS Therapeutic Treatment Now Coalition to unveil ambitious pledge at Bangkok 2004

Endo announces agreement With FDA for new trial design of oxymorphone extended-release tablets

Pfizer focuses on enabling America's 43 million uninsured to obtain medicines at significant savings

Presidential Decree will have a direct negative impact on the health of millions of Ecuadorians

Nanotechnology-based applications are accelerating the development of nanomedicine

Enzymes from king crab are an effective treatment for scalds, sores, and trophic ulcers

Medicine storage temperatures are too high

Gum disease vaccination aim of world-first research

Generic fixed-dose combinations (FDCs) of antiretrovirals are a key factor in access to treatment of HIV/AIDS infection in the developing world

No compulsory genetic testing for newborn babies in Europe

U.S. drug prices rise by 3.4 percent during the first quarter of 2004, elderly especially hard hit

New drug application for cilansetron, an investigational product for the treatment of irritable bowel syndrome

New web site dedicated to improving the accuracy of medical news stories

New drug application for regulatory approval of exenatide for the treatment of type 2 diabetes

A Center for Human Genetics/Genomics has been established at the University of California

Ethical, social and legal aspects of human genetic testing

Industry Focus - Biopharma eBook

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest Life Science News